<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03903666</url>
  </required_header>
  <id_info>
    <org_study_id>TriRespi</org_study_id>
    <nct_id>NCT03903666</nct_id>
  </id_info>
  <brief_title>Anomalies of Nocturnal Gaz Exchanges in Patients With Down Syndrome</brief_title>
  <official_title>Anomalies of Nocturnal Gaz Exchanges in Patients With Down Syndrome Aged From 4 to 16 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Jerome Lejeune</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hôpital Armand Trousseau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut Jerome Lejeune</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recently, retrospective studies have shown that Down Syndrome children have a higher CO2
      (carbone dioxide) sleep pressure than the general pediatric population. This increase does
      not seem to be always related to sleep apnea. The Investigators wish to confirm these results
      prospectively. The investigators hypothesize that this alveolar hypoventilation may be due to
      ventilatory control disorders caused by dysautonomia, but also to a decrease in the strength
      of the respiratory muscles within the framework of the global muscular hypotonia described in
      children with Down syndrome. .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      47 Down syndrome patients age from 4 to 16 will be included. They will perform a medical
      visit at J0, then a measurement of gaz nocturnal exchanges at home within 1 month
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 14, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Down syndrome patients aged from 4 to 16 years</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with high mean PtcCO2 as assessed by nocturnal gas exchange recordings</measure>
    <time_frame>2 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of total sleep time with a PtcCO2 in mmHg higher than 50; mean, maximum and minimum SpO2 in %</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with low mean, minimum and maximum SpO2 (oyxygen saturation) and/or % of Total sleep time spent with a PtcCO2 higher than 50 mmHg, higher than 20%, as measured by nocturnal gas exchange recordings.</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between nocturnal PtcCO2 value and the existence of executive function and behavioral disorders assed by the Dysautonomia questionnaire</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between nocturnal PtcCO2 value and the existence of executive function and behavioral disorders measured by Hand Grip assessment</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between nocturnal PtcCO2 value and the existence of executive function and behavioral disorders measured by OSA (Obstructive Sleep Apnea) assessment questionnaire</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">47</enrollment>
  <condition>Down Syndrome</condition>
  <arm_group>
    <arm_group_label>Cohort</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>47 Down syndrome patients age from 4 to 16</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nocturnal gaz exchanges measurement</intervention_name>
    <description>Nocturnal gaz exchanges at patient's home BRIEF neuropsychological questionnaire VINELAND-II neuropsychological questionnaire Clinical OSA assessment Dysautonomia assessment</description>
    <arm_group_label>Cohort</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Down syndrome patient without mosaicism

          -  Age 4 to 16 years

          -  Predominant French language in the living environment

        Exclusion Criteria:

          -  OAS diagnostic focused on an earlier polysomnography

          -  Methylphenidate treatment started before inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>TAYTARD MD Jessica</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Armand Trousseau</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>TAYTARD MD Jessica</last_name>
    <phone>+33 1 71 73 84 11</phone>
    <email>jessica.taytard@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>RAVEL MD Aîmé</last_name>
    <phone>+ 33 1 56 58 63 00</phone>
    <email>aimé.walti@institutlejeune.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Armand Trousseau</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>TAYTARD MD Jessica</last_name>
      <phone>+ 33 1 71 73 87 11</phone>
      <email>jessica.taytard@aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>RICHARD MD Nicolas</last_name>
      <phone>+ 33 1 71 73 87 11</phone>
      <email>nicolas.richard@aphp.fr</email>
    </contact_backup>
    <investigator>
      <last_name>AUBERTIN MD Guillaume</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Feldman JL, Del Negro CA, Gray PA. Understanding the rhythm of breathing: so near, yet so far. Annu Rev Physiol. 2013;75:423-52. doi: 10.1146/annurev-physiol-040510-130049. Epub 2012 Oct 29. Review.</citation>
    <PMID>23121137</PMID>
  </reference>
  <reference>
    <citation>Trang H, Brunet JF, Rohrer H, Gallego J, Amiel J, Bachetti T, Fischbeck KH, Similowski T, Straus C, Ceccherini I, Weese-Mayer DE, Frerick M, Bieganowska K, Middleton L, Morandi F, Ottonello G; European Central Hypoventilation Syndrome Consortium. Proceedings of the fourth international conference on central hypoventilation. Orphanet J Rare Dis. 2014 Dec 5;9:194. doi: 10.1186/s13023-014-0194-5. Review.</citation>
    <PMID>25928806</PMID>
  </reference>
  <reference>
    <citation>Ng DK, Hui HN, Chan CH, Kwok KL, Chow PY, Cheung JM, Leung SY. Obstructive sleep apnoea in children with Down syndrome. Singapore Med J. 2006 Sep;47(9):774-9.</citation>
    <PMID>16924359</PMID>
  </reference>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>March 23, 2019</study_first_submitted>
  <study_first_submitted_qc>April 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2019</study_first_posted>
  <last_update_submitted>October 25, 2019</last_update_submitted>
  <last_update_submitted_qc>October 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sleep Apnoa</keyword>
  <keyword>Down Syndrome</keyword>
  <keyword>Children</keyword>
  <keyword>OSA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Down Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

